Clinical Trials Logo

Clinical Trial Summary

The goal of this research study is to learn if certain factors may affect cancer rates among African Americans. These factors include behavioral, social, and environmental factors including diet and physical activity, cigarette smoking, cancer screening, health care, neighborhood environment, and mental health.


Clinical Trial Description

Study Procedures:

If you decide to take part in this study, you will complete study procedures at month 36 (the day you sign this consent form) and again every year for the next 2 years. These procedures include completing a questionnaire, having your body measurements taken, and receiving self-help materials.

At month 36, you will complete the questionnaire on a computer that is set up at the church in a private room. The questions will be about nutrition, exercise, tobacco and alcohol use, your neighborhood, age, education, social status, health status, stress, and racism. It should take about 75 minutes to complete. Your waist, hip, height, and weight will also be measured while you are in the private room.

Every year after that for the next 2 years, you will go back to the church to complete a new questionnaire each time. The questionnaires should take about 75 minutes to complete each time.

If you cannot get back to the church, you may complete the questionnaire over the phone. The study staff will provide you with the phone number and directions on how to complete the survey over the phone. Your measurements will be taken at the church, or at the Behavioral Research and Treatment Center (BRTC) at MD Anderson, whichever is more convenient for you.

At each study visit, you will also receive self-help materials on how to lower your risk for developing cancer.

Questionnaire Data:

Your questionnaire data will be used for research purposes only. Your responses will not be shared with your personal doctor. If you feel you need a doctor's opinion about anything that is asked about in the questionnaire (such as mental or emotional difficulties or symptoms), please contact your personal physician.

About 1 month after each you complete the questionnaire each time, the research staff will review and score your responses. If your scores suggest signs of depression, you will be given a list of resources for mental health screening.

Length of Study:

After 5 years, your active participation in this study will be over. You may be contacted in the future to see if you would agree to take part in other research studies.

This is an investigational study.

Up to 1,501 people will take part in this study. All will be enrolled at MD Anderson. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00823394
Study type Observational
Source M.D. Anderson Cancer Center
Contact
Status Active, not recruiting
Phase
Start date December 5, 2008
Completion date December 31, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients